| Autor: |
Cho E; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.; Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea., Singh R; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea., Han C; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Republic of Korea., Kim SH; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.; Department of Biomedical Laboratory Science, Catholic Kwandong University, Gangneung, 25601, Republic of Korea., Kim KH; Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea., Park BM; Biomedicine Production Branch, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea., Shin DH; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Republic of Korea.; Anticancer Resistance Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea., Han S; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea., Kim YH; Eutilex Co., Ltd., Geumcheon-gu, Seoul, 08594, Republic of Korea., Kwon BS; Eutilex Co., Ltd., Geumcheon-gu, Seoul, 08594, Republic of Korea.; Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA, 70112, USA., Nam KT; Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea. kitaek@yuhs.ac., Choi BK; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea. magetin@gmail.com.; Innobationbio Co., Ltd., Mapo-gu, Seoul, 03929, Republic of Korea. magetin@gmail.com. |
Full text from SpringerLink